The DOI matches its Crossref record; 218 of the 218 references it cites were found in a registry or an index.
Active targeting of brain tumors using nanocarriers
Abstract
The delivery of drugs to brain tumors is limited by the presence of the blood-brain barrier (BBB) separating the blood from the cerebral parenchyma. An understanding of the specific mechanisms of the brain capillary endothelium has led to the development of various strategies to enhance the penetration of drugs into the brain tissue. Active targeting is a non-invasive approach, which consists in transporting drugs to target organs using site-specific ligands. Drug-loaded nanocarriers capable of recognizing brain capillary endothelial cells and cerebral tumoral cells have shown promising potential in oncology. Endogenous and chimeric ligands binding to carriers or receptors of the BBB have been directly or indirectly conjugated to nanocarriers. This review indexes the main targeted colloidal systems used for drug delivery to the brain. Their pharmacological behavior and their therapeutic effect are discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Continuous cultures of fused cells secreting antibody of predefined specificity
KÖHLER, G., & MILSTEIN, C. (1975) · Nature · doi:10.1038/256495a0 · Cited by 17,229
Angiogenesis in cancer, vascular, rheumatoid and other disease
Folkman, J. (1995) · Nature Medicine · doi:10.1038/nm0195-27 · Cited by 7,627
Biodegradable Long-Circulating Polymeric Nanospheres
Gref, R., Minamitake, Y., Peracchia, M. T., Trubetskoy, V., Torchilin, V., & Langer, R. (1994) · Science · doi:10.1126/science.8128245 · Cited by 2,920
FINE STRUCTURAL LOCALIZATION OF A BLOOD-BRAIN BARRIER TO EXOGENOUS PEROXIDASE
Reese, T. S., & Karnovsky, M. J. (1967) · The Journal of Cell Biology · doi:10.1083/jcb.34.1.207 · Cited by 2,629
JUNCTIONS BETWEEN INTIMATELY APPOSED CELL MEMBRANES IN THE VERTEBRATE BRAIN
Brightman, M. W., & Reese, T. S. (1969) · The Journal of Cell Biology · doi:10.1083/jcb.40.3.648 · Cited by 2,471
Nanocapsule formation by interfacial polymer deposition following solvent displacement
Fessi, H., Puisieux, F., Devissaguet, J. P., Ammoury, N., & Benita, S. (1989) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(89)90281-0 · Cited by 2,288
Protein—surface interactions in the presence of polyethylene oxide
Jeon, S. I., Lee, J. H., Andrade, J. D., & De Gennes, P. G. (1991) · Journal of Colloid and Interface Science · doi:10.1016/0021-9797(91)90043-8 · Cited by 1,523
Block copolymer micelles: preparation, characterization and application in drug delivery
Gaucher, G., Dufresne, M.-H., Sant, V. P., Kang, N., Maysinger, D., & Leroux, J.-C. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.09.034 · Cited by 1,498
Solid lipid nanoparticles for parenteral drug delivery
Wissing, S. A., Kayser, O., & Müller, R. H. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.12.002 · Cited by 1,495
Chitosan and Its Use as a Pharmaceutical Excipient
Ilium, L. (1998) · Pharmaceutical Research · doi:10.1023/a:1011929016601 · Cited by 1,396
Brem, H., Piantadosi, S., Burger, P. C., Walker, M., Selker, R., Vick, N. A., Black, K., Sisti, M., Brem, S., Mohr, G., et al. (1995) · The Lancet · doi:10.1016/s0140-6736(95)90755-6 · Cited by 1,389
Westphal, M., Hilt, D. C., Bortey, E., Delavault, P., Olivares, R., Warnke, P. C., Whittle, I. R., Jääskeläinen, J., & Ram, Z. (2003) · Neuro-Oncology · doi:10.1093/neuonc/5.2.79 · Cited by 1,330
Moghimi, S. M., & Szebeni, J. (2003) · Progress in Lipid Research · doi:10.1016/s0163-7827(03)00033-x · Cited by 1,227
Nanostructured lipid matrices for improved microencapsulation of drugs
Müller, R. H., Radtke, M., & Wissing, S. A. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00180-1 · Cited by 1,226
Primary brain tumours in adults
Ricard, D., Idbaih, A., Ducray, F., Lahutte, M., Hoang-Xuan, K., & Delattre, J.-Y. (2012) · The Lancet · doi:10.1016/s0140-6736(11)61346-9 · Cited by 1,201
Nanoparticulate systems for brain delivery of drugs.
Kreuter, J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00122-8 · Cited by 1,107
Transferrin receptor on endothelium of brain capillaries
Jefferies, W. A., Brandon, M. R., Hunt, S. V., Williams, A. F., Gatter, K. C., & Mason, D. Y. (1984) · Nature · doi:10.1038/312162a0 · Cited by 1,061
Nishiyama, N., & Kataoka, K. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.05.006 · Cited by 1,052
Michael Green, N. (1990) · Methods in Enzymology · doi:10.1016/0076-6879(90)84259-j · Cited by 1,027
Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues.
Weitman, S. D., Lark, R. H., Coney, L. R., Fort, D. W., Frasca, V., Zurawski, V. R., & Kamen, B. A. (1992) · PubMed · Cited by 1,011
Nanoparticulate systems for brain delivery of drugs
Kreuter, J. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.015 · Cited by 958
Ion-Induced Morphological Changes in “Crew-Cut” Aggregates of Amphiphilic Block Copolymers
Zhang, L., Yu, K., & Eisenberg, A. (1996) · Science · doi:10.1126/science.272.5269.1777 · Cited by 913
Ross, J. F., Chaudhuri, P. K., & Ratnam, M. (1994) · Cancer · doi:10.1002/1097-0142(19940501)73:9<2432::aid-cncr2820730929>3.0.co;2-s · Cited by 891
Calvo, P., Remuñan-López, C., Vila-Jato, J. L., & Alonso, M. J. (1997) · Pharmaceutical Research · doi:10.1023/a:1012128907225 · Cited by 817
Insulin-like Growth Factor Binding Proteins
Rechler, M. M. (1993) · Vitamins & Hormones · doi:10.1016/s0083-6729(08)60444-6 · Cited by 755
Primary brain tumours in adults
Behin, A., Hoang-Xuan, K., Carpentier, A. F., & Delattre, J.-Y. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12328-8 · Cited by 754
Brain drug delivery of small molecules using immunoliposomes
Huwyler, J., Wu, D., & Pardridge, W. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.14164 · Cited by 656
Folate receptor targeted biodegradable polymeric doxorubicin micelles
Yoo, H. S., & Park, T. G. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.02.003 · Cited by 620
Nanoparticle Technology for Drug Delivery Across the Blood-Brain Barrier
Lockman, P. R., Mumper, R. J., Khan, M. A., & Allen, D. D. (2002) · Drug Development and Industrial Pharmacy · doi:10.1081/ddc-120001481 · Cited by 592
A Novel Phase Inversion-Based Process for the Preparation of Lipid Nanocarriers
Heurtault, B., Saulnier, P., Pech, B., Proust, J.-E., & Benoit, J.-P. (2002) · Pharmaceutical Research · doi:10.1023/a:1016121319668 · Cited by 583
Self-citationFolate-mediated tumor cell targeting of liposome-entrapped doxorubicin in vitro
Lee, R. J., & Low, P. S. (1995) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(94)00235-h · Cited by 574
Development of the polymer micelle carrier system for doxorubicin
Nakanishi, T., Fukushima, S., Okamoto, K., Suzuki, M., Matsumura, Y., Yokoyama, M., Okano, T., Sakurai, Y., & Kataoka, K. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00341-8 · Cited by 570
Design of Folic Acid‐Conjugated Nanoparticles for Drug Targeting
Stella, B., Arpicco, S., Peracchia, M. T., Desmaële, D., Hoebeke, J., Renoir, M., D'Angelo, J., Cattel, L., & Couvreur, P. (2000) · Journal of Pharmaceutical Sciences · doi:10.1002/1520-6017(200011)89:11<1452::aid-jps8>3.0.co;2-p · Cited by 553
Receptor‐mediated transcytosis of transferrin across the blood‐brain barrier
Fishman, J. B., Rubin, J. B., Handrahan, J. V., Connor, J. R., & Fine, R. E. (1987) · Journal of Neuroscience Research · doi:10.1002/jnr.490180206 · Cited by 544
Targeted polymeric micelles for delivery of poorly soluble drugs
Torchilin, V. P. (2004) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-004-4153-5 · Cited by 543
Passage of peptides through the blood-brain barrier with colloidal polymer particles (nanoparticles)
Kreuter, J., Alyautdin, R. N., Kharkevich, D. A., & Ivanov, A. A. (1995) · Brain Research · doi:10.1016/0006-8993(95)00023-j · Cited by 539
Laske, D. W., Youle, R. J., & Oldfield, E. H. (1997) · Nature Medicine · doi:10.1038/nm1297-1362 · Cited by 525
Significant Transport of Doxorubicin into the Brain with Polysorbate 80-Coated Nanoparticles
Gulyaev, A. E., Gelperina, S. E., Skidan, I. N., Antropov, A. S., Kivman, G. Y., & Kreuter, J. (1999) · Pharmaceutical Research · doi:10.1023/a:1018983904537 · Cited by 521
The transferrin receptor part II: Targeted delivery of therapeutic agents into cancer cells
Daniels, T. R., Delgado, T., Helguera, G., & Penichet, M. L. (2006) · Clinical Immunology · doi:10.1016/j.clim.2006.06.006 · Cited by 518
A New Function for the LDL Receptor: Transcytosis of LDL across the Blood–Brain Barrier
Dehouck, B., Fenart, L., Dehouck, M.-P., Pierce, A., Torpier, G., & Cecchelli, R. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.138.4.877 · Cited by 490
Anderson, R. G. W., Brown, M. S., & Goldstein, J. L. (1977) · Cell · doi:10.1016/0092-8674(77)90022-8 · Cited by 489
Freitas, C., & Müller, R. H. (1999) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(98)00074-5 · Cited by 483
Delivery of peptides and proteins through the blood–brain barrier
Bickel, U., Yoshikawa, T., & Pardridge, W. M. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00139-3 · Cited by 481
Szoka, F., Olson, F., Heath, T., Vail, W., Mayhew, E., & Papahadjopoulos, D. (1980) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(80)90558-1 · Cited by 474
Kreuter, J., Ramge, P., Petrov, V., Hamm, S., Gelperina, S. E., Engelhardt, B., Alyautdin, R., von Briesen, H., & Begley, D. J. (2003) · Pharmaceutical Research · doi:10.1023/a:1022604120952 · Cited by 469
Gabizon, A., Horowitz, A. T., Goren, D., Tzemach, D., Mandelbaum-Shavit, F., Qazen, M. M., & Zalipsky, S. (1999) · Bioconjugate Chemistry · doi:10.1021/bc9801124 · Cited by 468
Gabizon, A. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.01.011 · Cited by 464
Triguero, D., Buciak, J., & Pardridge, W. M. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb04886.x · Cited by 460
Couvreur, P., Kante, B., Roland, M., Guiot, P., Bauduin, P., & Speiser, P. (1979) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1979.tb13510.x · Cited by 452
Shinoda, K., & Saito, H. (1969) · Journal of Colloid and Interface Science · doi:10.1016/s0021-9797(69)80012-3 · Cited by 451
Long-circulating (sterically stabilized) liposomes for targeted drug delivery
Allen, T. M. (1994) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(94)90314-x · Cited by 445
Drug transport to brain with targeted nanoparticles
Olivier, J.-C. (2005) · NeuroRX · doi:10.1602/neurorx.2.1.108 · Cited by 444
Long-circulating pegylated polycyanoacrylate nanoparticles as new drug carrier for brain delivery.
Calvo, P., Gouritin, B., Chacun, H., Desmaële, D., D'Angelo, J., Noel, J.-P., Georgin, D., Fattal, E., Andreux, J. P., & Couvreur, P. (2001) · Pharmaceutical Research · doi:10.1023/a:1010931127745 · Cited by 443
Yamamoto, Y., Nagasaki, Y., Kato, Y., Sugiyama, Y., & Kataoka, K. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00451-5 · Cited by 442
Drug and gene targeting to the brain with molecular trojan horses
Pardridge, W. M. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd725 · Cited by 439
Seymour, L. W., Duncan, R., Strohalm, J., & Kopeček, J. (1987) · Journal of Biomedical Materials Research · doi:10.1002/jbm.820211106 · Cited by 436
Chemotherapy of glioblastoma in rats using doxorubicin‐loaded nanoparticles
Steiniger, S. C. J., Kreuter, J., Khalansky, A. S., Skidan, I. N., Bobruskin, A. I., Smirnova, Z. S., Severin, S. E., Uhl, R., Kock, M., Geiger, K. D., et al. (2004) · International Journal of Cancer · doi:10.1002/ijc.20048 · Cited by 434
Westphal, M., Ram, Z., Riddle, V., Hilt, D., Bortey, E., & On behalf of the Executive Committee of the Gliadel® Study Group (2006) · Acta Neurochirurgica · doi:10.1007/s00701-005-0707-z · Cited by 420
Peracchia, M. T., Fattal, E., Desmaële, D., Besnard, M., Noël, J. P., Gomis, J. M., Appel, M., d’Angelo, J., & Couvreur, P. (1999) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00063-2 · Cited by 400
Human Blood—Brain Barrier Insulin Receptor
Pardridge, W. M., Eisenberg, J., & Yang, J. (1985) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1985.tb07167.x · Cited by 399
Insulin-like growth factors cross the blood-brain barrier
Reinhardt, R., & Bondy, C. A. (1994) · Endocrinology · doi:10.1210/en.135.5.1753 · Cited by 391
La, S. B., Okano, T., & Kataoka, K. (1996) · Journal of Pharmaceutical Sciences · doi:10.1021/js950204r · Cited by 379
Blood-brain barrier transcytosis of insulin in developing rabbits
Duffy, K. R., & Pardridge, W. M. (1987) · Brain Research · doi:10.1016/0006-8993(87)90236-8 · Cited by 358
Pardridge, W. M., Buciak, J. L., & Friden, P. M. (1991) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20567-5 · Cited by 358
Human blood-brain barrier transferrin receptor
Pardridge, W. M., Eisenberg, J., & Yang, J. (1987) · Metabolism · doi:10.1016/0026-0495(87)90099-0 · Cited by 356
Alyautdin, R. N., Petrov, V. E., Langer, K., Berthold, A., Kharkevich, D. A., & Kreuter, J. (1997) · Pharmaceutical Research · doi:10.1023/a:1012098005098 · Cited by 352
Pardridge, W. M. (1997) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199707000-00001 · Cited by 328
Brain cancer diagnosis and therapy with nanoplatforms☆
KOO, Y., REDDY, G., BHOJANI, M., SCHNEIDER, R., PHILBERT, M., REHEMTULLA, A., ROSS, B., & KOPELMAN, R. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.09.012 · Cited by 326
Kumagai, A. K., Eisenberg, J. B., & Pardridge, W. M. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)48160-4 · Cited by 325
Aktaş, Y., Yemisci, M., Andrieux, K., Gürsoy, R. N., Alonso, M. J., Fernandez-Megia, E., Novoa-Carballal, R., Quiñoá, E., Riguera, R., Sargon, M. F., et al. (2005) · Bioconjugate Chemistry · doi:10.1021/bc050217o · Cited by 318
Cationic albumin-conjugated pegylated nanoparticles as novel drug carrier for brain delivery
Lu, W., Zhang, Y., Tan, Y.-Z., Hu, K.-L., Jiang, X.-G., & Fu, S.-K. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.03.027 · Cited by 311
Controlled targeting of liposomal doxorubicin via the folate receptor in vitro
Saul, J. M., Annapragada, A., Natarajan, J. V., & Bellamkonda, R. V. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00295-5 · Cited by 303
Michaelis, K., Hoffmann, M. M., Dreis, S., Herbert, E., Alyautdin, R. N., Michaelis, M., Kreuter, J., & Langer, K. (2006) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.097139 · Cited by 303
Hydrogen Bonding. 33. Factors That Influence the Distribution of Solutes between Blood and Brain
Abraham, M. H., Chadha, H. S., & Mitchell, R. C. (1994) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600830915 · Cited by 301
Paclitaxel nanoparticles for the potential treatment of brain tumors
Koziara, J. M., Lockman, P. R., Allen, D. D., & Mumper, R. J. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.07.006 · Cited by 299
Göppert, T. M., & Müller, R. H. (2005) · Journal of Drug Targeting · doi:10.1080/10611860500071292 · Cited by 299
Uster, P. S., Allen, T. M., Daniel, B. E., Mendez, C. J., Newman, M. S., & Zhu, G. Z. (1996) · FEBS Letters · doi:10.1016/0014-5793(96)00452-8 · Cited by 298
Kabanov, A. V., Batrakova, E. V., Melik-Nubarov, N. S., Fedoseev, N. A., Dorodnich, T. Y., Alakhov, V. Y., Chekhonin, V. P., Nazarova, I. R., & Kabanov, V. A. (1992) · Journal of Controlled Release · doi:10.1016/0168-3659(92)90199-2 · Cited by 295
Mosqueira, V. C. F., Legrand, P., Morgat, J.-L., Vert, M., Mysiakine, E., Gref, R., Devissaguet, J.-P., & Barratt, G. (2001) · Pharmaceutical Research · doi:10.1023/a:1012248721523 · Cited by 289
Insulinlike Growth Factor-Binding Proteins
ROSENFELD, R. G., LAMSON, G., PHAM, H., OH, Y., CONOVER, C., DE LEON, D. D., DONOVAN, S. M., OCRANT, I., & GIUDICE, L. (1990) · Proceedings of the 1989 Laurentian Hormone Conference · doi:10.1016/b978-0-12-571146-3.50009-2 · Cited by 285
Transport of small molecules through the blood-brain barrier: biology and methodology
Pardridge, W. M. (1995) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00003-p · Cited by 279
Peltier, S., Oger, J.-M., Lagarce, F., Couet, W., & Benoît, J.-P. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-0022-2 · Cited by 274
Tedeschi, G., Lundbom, N., Raman, R., Bonavita, S., Duyn, J. H., Alger, J. R., & Chiro, G. D. (1997) · Journal of Neurosurgery · doi:10.3171/jns.1997.87.4.0516 · Cited by 268
Maruyama, K., Takizawa, T., Yuda, T., Kennel, S. J., Huang, L., & Iwatsuru, M. (1995) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(94)00263-o · Cited by 265
Brain uptake of thiamine-coated nanoparticles
Lockman, P. R., Oyewumi, M. O., Koziara, J. M., Roder, K. E., Mumper, R. J., & Allen, D. D. (2003) · Journal of Controlled Release · doi:10.1016/j.jconrel.2003.08.006 · Cited by 259
Matsumura, Y., Gotoh, M., Muro, K., Yamada, Y., Shirao, K., Shimada, Y., Okuwa, M., Matsumoto, S., Miyata, Y., Ohkura, H., et al. (2004) · Annals of Oncology · doi:10.1093/annonc/mdh092 · Cited by 253
Noninvasive gene targeting to the brain
Shi, N., & Pardridge, W. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.130187497 · Cited by 252
Development of a new process for the manufacture of polyisobutylcyanoacrylate nanocapsules
Al Khouri Fallouh, N., Roblot-Treupel, L., Fessi, H., Devissaguet, J. P., & Puisieux, F. (1986) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(86)90236-x · Cited by 251
Nagasaki, Y., Okada, T., Scholz, C., Iijima, M., Kato, M., & Kataoka, K. (1998) · Macromolecules · doi:10.1021/ma971294k · Cited by 245
Dehouck, B., Dehouck, M. P., Fruchart, J. C., & Cecchelli, R. (1994) · The Journal of cell biology · doi:10.1083/jcb.126.2.465 · Cited by 240
Park, E. K., Kim, S. Y., Lee, S. B., & Lee, Y. M. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.09.039 · Cited by 239
Measurement of endosome pH following folate receptor-mediated endocytosis
Lee, R. J., Wang, S., & Low, P. S. (1996) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/0167-4889(96)00041-9 · Cited by 232
Calvo, P., Remuñán-López, C., Vila-Jato, J. L., & Alonso, M. J. (1997) · Colloid & Polymer Science · doi:10.1007/s003960050050 · Cited by 227
Peptide drug modifications to enhance bioavailability and blood-brain barrier permeability
Witt, K. A., Gillespie, T. J., Huber, J. D., Egleton, R. D., & Davis, T. P. (2001) · Peptides · doi:10.1016/s0196-9781(01)00537-x · Cited by 227
Rationale for Design of Biologically Reversible Drug Derivatives: Prodrugs
Sinkula, A. A., & Yalkowsky, S. H. (1975) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600640203 · Cited by 223
Developmental changes in transferrin and iron uptake by the brain in the rat
Taylor, E. M., & Morgan, E. H. (1990) · Developmental Brain Research · doi:10.1016/0165-3806(90)90103-6 · Cited by 221
CARRIER MEDIATED BLOOD‐BRAIN BARRIER TRANSPORT OF CHOLINE AND CERTAIN CHOLINE ANALOGS
Cornford, E. M., Braun, L. D., & Oldendorf, W. H. (1978) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1978.tb06530.x · Cited by 220
Lu, W., Sun, Q., Wan, J., She, Z., & Jiang, X.-G. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2354 · Cited by 219
Synthesis of Pegylated Immunonanoparticles
Olivier, J.-C., Huertas, R., Lee, H. J., Calon, F., & Pardridge, W. M. (2002) · Pharmaceutical Research · doi:10.1023/a:1019842024814 · Cited by 217
Specific role of polysorbate 80 coating on the targeting of nanoparticles to the brain
Sun, W., Xie, C., Wang, H., & Hu, Y. (2004) · Biomaterials · doi:10.1016/j.biomaterials.2003.09.087 · Cited by 215
Olivier, J.-C., Fenart, L., Chauvet, R., Pariat, C., Cecchelli, R., & Couet, W. (1999) · Pharmaceutical Research · doi:10.1023/a:1018947208597 · Cited by 213
Wolburg, H., Wolburg-Buchholz, K., Liebner, S., & Engelhardt, B. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)01927-9 · Cited by 210
Triguero, D., Buciak, J. B., Yang, J., & Pardridge, W. M. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.12.4761 · Cited by 210
Small molecular drug transfer across the blood-brain barrier via carrier-mediated transport systems
Tsuji, A. (2005) · NeuroRX · doi:10.1602/neurorx.2.1.54 · Cited by 209
Receptor-mediated endocytosis of transferrin at the blood-brain barrier
Roberts, R. L., Fine, R. E., & Sandra, A. (1993) · Journal of Cell Science · doi:10.1242/jcs.104.2.521 · Cited by 203
Immunogenicity and pharmacokinetic attributes of poly(ethylene glycol)-grafted immunoliposomes
Harding, J. A., Engbers, C. M., Newman, M. S., Goldstein, N. I., & Zalipsky, S. (1997) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(97)00056-4 · Cited by 202
Surface-engineered nanoparticles for multiple ligand coupling
Gref, R., Couvreur, P., Barratt, G., & Mysiakine, E. (2003) · Biomaterials · doi:10.1016/s0142-9612(03)00348-x · Cited by 197
Ramge, P., Unger, R. E., Oltrogge, J. B., Zenker, D., Begley, D., Kreuter, J., & Von Briesen, H. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00078.x · Cited by 197
Kreuter, J., Petrov, V. E., Kharkevich, D. A., & Alyautdin, R. N. (1997) · Journal of Controlled Release · doi:10.1016/s0168-3659(97)00061-8 · Cited by 196
Pegylated liposomal doxorubicin‐efficacy in patients with recurrent high‐grade glioma
Hau, P., Fabel, K., Baumgart, U., Rümmele, P., Grauer, O., Bock, A., Dietmaier, C., Dietmaier, W., Dietrich, J., Dudel, C., et al. (2004) · Cancer · doi:10.1002/cncr.20073 · Cited by 196
Fenart, L., Casanova, A., Dehouck, B., Duhem, C., Slupek, S., Cecchelli, R., & Betbeder, D. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35204-8 · Cited by 196
Gelperina, S. E., Khalansky, A. S., Skidan, I. N., Smirnova, Z. S., Bobruskin, A. I., Severin, S. E., Turowski, B., Zanella, F. E., & Kreuter, J. (2002) · Toxicology Letters · doi:10.1016/s0378-4274(01)00456-8 · Cited by 185
Insulin binds to brain blood vessels in vivo
van Houten, M., & Posner, B. I. (1979) · Nature · doi:10.1038/282623a0 · Cited by 180
Olbrich, C., Gessner, A., Kayser, O., & Müller, R. H. (2002) · Journal of Drug Targeting · doi:10.1080/1061186021000001832 · Cited by 175
Lockman, P. R., & Allen, D. D. (2002) · Drug Development and Industrial Pharmacy · doi:10.1081/ddc-120005622 · Cited by 174
Blood–Brain Barrier Efflux Transport
Golden, P. L., & Pollack, G. M. (2003) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10424 · Cited by 174
A Direct In Vitro Demonstration of Insulin Binding to Isolated Brain Microvessels
Frank, H. J. L., & Pardridge, W. M. (1981) · Diabetes · doi:10.2337/diab.30.9.757 · Cited by 172
Sarmento, B., Martins, S., Ribeiro, A., Veiga, F., Neufeld, R., & Ferreira, D. (2006) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-005-9010-3 · Cited by 171
Maruyama, K., Takahashi, N., Tagawa, T., Nagaike, K., & Iwatsuru, M. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00905-8 · Cited by 170
Moos, T., & Morgan, E. H. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00541.x · Cited by 169
de Verdière, A., Dubernet, C., Némati, F., Soma, E., Appel, M., Ferté, J., Bernard, S., Puisieux, F., & Couvreur, P. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.362 · Cited by 168
Lü, W., Tan, Y.-Z., Hu, K., & Jiang, X. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.01.043 · Cited by 168
Gene expression of GLUT3 and GLUT1 glucose transporters in human brain tumors
Boado, R. J., Black, K. L., & Pardridge, W. M. (1994) · Molecular Brain Research · doi:10.1016/0169-328x(94)90183-x · Cited by 168
New Synthetic Amphiphilic Polymers for Steric Protection of Liposomes in Vivo
Torchilin, V. P., Trubetskoy, V. S., Whiteman, K. R., Ferruti, P., Veronese, F. M., & Caliceti, P. (1995) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600840904 · Cited by 168
Lamprecht, A., & Benoit, J.-P. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.02.014 · Cited by 167
Self-citationPreparation and characterization of solid lipid nanospheres containing paclitaxel
Cavalli, R., Caputo, O., & Gasco, M. R. (2000) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(00)00081-6 · Cited by 167
Receptor-mediated transcytosis of transferrin through blood-brain barrier endothelial cells
Descamps, L., Dehouck, M. P., Torpier, G., & Cecchelli, R. (1996) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1996.270.4.h1149 · Cited by 166
Design of targeted lipid nanocapsules by conjugation of whole antibodies and antibody Fab’ fragments
Béduneau, A., Saulnier, P., Hindré, F., Clavreul, A., Leroux, J.-C., & Benoit, J.-P. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2007.05.014 · Cited by 161
Self-citationGosk, S., Vermehren, C., Storm, G., & Moos, T. (2004) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/01.wcb.0000135592.28823.47 · Cited by 160
Lherm, C., Müller, R. H., Puisieux, F., & Couvreur, P. (1992) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(92)90210-s · Cited by 159
Ultracytochemical characterization of anionic sites in the wall of brain capillaries
VORBRODT, A. W. (1989) · Journal of Neurocytology · doi:10.1007/bf01190839 · Cited by 157
Khalid, M. N., Simard, P., Hoarau, D., Dragomir, A., & Leroux, J. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-9662-5 · Cited by 157
Schöler, N., Krause, K., Kayser, O., Müller, R. H., Borner, K., Hahn, H. H., & Liesenfeld, O. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.6.1771-1779.2001 · Cited by 155
A Folate Receptor?Targeted Lipid Nanoparticle Formulation for a Lipophilic Paclitaxel Prodrug
Stevens, P. J., Sekido, M., & Lee, R. J. (2004) · Pharmaceutical Research · doi:10.1007/s11095-004-7667-5 · Cited by 154
Experience with the Subcutaneous Cerebrospinal-Fluid Reservoir
Ratcheson, R. A., & Ommaya, A. K. (1968) · New England Journal of Medicine · doi:10.1056/nejm196811072791904 · Cited by 154
Local delivery of doxorubicin for the treatment of malignant brain tumors in rats.
Lesniak, M. S., Upadhyay, U. M., Goodwin, R. M., Tyler, B., & Brem, H. (2005) · PubMed · Cited by 152
Trubetskoy, V. S., & Torchilin, V. P. (1995) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00032-3 · Cited by 148
Hatakeyama, H., Akita, H., Maruyama, K., Suhara, T., & Harashima, H. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.05.025 · Cited by 147
Antisense Gene Therapy of Brain Cancer with an Artificial Virus Gene Delivery System
Zhang, Y., Zhu, C., & Pardridge, W. M. (2002) · Molecular Therapy · doi:10.1006/mthe.2002.0633 · Cited by 144
Meneï, P., Venier‐Julienne, M., Gamelin, E., Saint‐André, J., Hayek, G., Jadaud, E., Fournier, D., Mercier, P., Guy, G., & Benoît, J. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19990715)86:2<325::aid-cncr17>3.0.co;2-s · Cited by 143
Low‐Density Lipoprotein Receptor on Endothelium of Brain Capillaries
Méresse, S., Delbart, C., Fruchart, J., & Cecchelli, R. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb07340.x · Cited by 143
Bennis, S., Chapey, C., Robert, J., & Couvreur, P. (1994) · European Journal of Cancer · doi:10.1016/s0959-8049(05)80025-5 · Cited by 142
Peracchia, M. T., Vauthier, C., Desmaële, D., Gulik, A., Dedieu, J., Demoy, M., d’Angelo, J., & Couvreur, P. (1998) · Pharmaceutical Research · doi:10.1023/a:1011973625803 · Cited by 141
Liposome targeting to mouse brain: Mannose as a recognition marker
Umezawa, F., & Yoshikatsu, E. T. O. (1988) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(88)81333-0 · Cited by 139
Nuclear translocation of the insulin receptor. A possible mediator of insulin's long term effects.
Podlecki, D. A., Smith, R. M., Kao, M., Tsai, P., Huecksteadt, T. P., Brandenburg, D., Lasher, R. S., Jarett, L., & Olefsky, J. M. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)61511-x · Cited by 138
Shmeeda, H., Mak, L., Tzemach, D., Astrahan, P., Tarshish, M., & Gabizon, A. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0543 · Cited by 137
Receptor‐mediated delivery of an antisense gene to human brain cancer cells
Zhang, Y., Lee, H. J., Boado, R. J., & Pardridge, W. M. (2002) · The Journal of Gene Medicine · doi:10.1002/jgm.255 · Cited by 132
Uptake and Distribution of Iron and Transferrin in the Adult Rat Brain
Morris, C. M., Keith, A. B., Edwardson, J. A., & Pullen, R. G. L. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb08904.x · Cited by 132
Sauer, I., Dunay, I. R., Weisgraber, K. H., Bienert, M., & Dathe, M. (2005) · Biochemistry · doi:10.1021/bi048080x · Cited by 131
Douglas, S. J., Illum, L., & Davis, S. S. (1985) · Journal of Colloid and Interface Science · doi:10.1016/0021-9797(85)90087-6 · Cited by 127
Allen, D. D., & Smith, Q. R. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00093.x · Cited by 125
Novel Long-Circulating Lipid Nanocapsules
Hoarau, D., Delmas, P., David, S., Roux, E., & Leroux, J. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000045229.87844.21 · Cited by 121
Ambruosi, A., Khalansky, A. S., Yamamoto, H., Gelperina, S. E., Begley, D. J., & Kreuter, J. (2006) · Journal of Drug Targeting · doi:10.1080/10611860600636135 · Cited by 119
Solid lipid nanoparticles can effectively bind DNA, streptavidin and biotinylated ligands
Pedersen, N. M., Hansen, S. H., Heydenreich, A. V., Kristensen, H. G., & Poulsen, H. S. (2005) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2005.09.003 · Cited by 117
Huwyler, J., Yang, J., & Pardridge, W. M. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36946-0 · Cited by 116
Bicarbonate transport across the frog choroid plexus and its control by cyclic nucleotides.
Saito, Y., & Wright, E. M. (1983) · The Journal of Physiology · doi:10.1113/jphysiol.1983.sp014602 · Cited by 114
Thöle, M., Nobmann, S., Huwyler, J., Bartmann, A., & Fricker, G. (2002) · Journal of drug targeting · doi:10.1080/10611860290031840 · Cited by 112
Antibody targeted gene transfer to endothelium
Tan, P., Manunta, M., Ardjomand, N., Xue, S., Larkin, F., Haskard, D. O., Taylor, K. M., & George, A. J. T. (2002) · The Journal of Gene Medicine · doi:10.1002/jgm.358 · Cited by 108
Endocytosis and Transcytosis of an Immunoliposome-Based Brain Drug Delivery System
Cerletti, A., Drewe, J., Fricker, G., Eberlé, A. N., & Huwyler, J. (2000) · Journal of drug targeting · doi:10.3109/10611860008997919 · Cited by 106
Bickel, U., Kang, Y., Yoshikawa, T., & Pardridge, W. M. (1994) · Journal of Histochemistry & Cytochemistry · doi:10.1177/42.11.7930531 · Cited by 104
Gao, Z., Lukyanov, A. N., Chakilam, A. R., & Torchilin, V. P. (2003) · Journal of drug targeting · doi:10.1080/1061186031000138623 · Cited by 104
Schnyder, A., Krähenbühl, S., Drewe, J., & Huwyler, J. (2005) · Journal of drug targeting · doi:10.1080/10611860500206674 · Cited by 104
Liposome-Mediated Modulation of Multidrug Resistance in Human HL-60 Leukemia Cells
Rahman, A., Husain, S. R., Siddiqui, J. I., Verma, M., Agresti, M., Safa, A. R., & Glazer, R. I. (1992) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/84.24.1909 · Cited by 104
Polymer Delivery of Camptothecin against 9L Gliosarcoma: Release, Distribution, and Efficacy
Storm, P. B., Moriarity, J. L., Tyler, B., Burger, P. C., Brem, H., & WEINGART, J. D. (2002) · Journal of Neuro-Oncology · doi:10.1023/a:1015003232713 · Cited by 103
Transferrin coupled liposomes as drug delivery carriers for brain targeting of 5-florouracil
Soni, V., Kohli, D. V., & Jain, S. K. (2005) · Journal of drug targeting · doi:10.1080/10611860500107401 · Cited by 103
Blood-brain barrier disruption using mannitol: time course and electron microscopy studies
Cosolo, W., Martinello, P., Louis, W. J., & Christophidis, N. (1989) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1989.256.2.r443 · Cited by 102
Cationization of protein antigens. I. Alteration of immunogenic properties.
Muckerheide, A., Apple, R. J., PESCE, A. J., & Michael, J. G. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.138.3.833 · Cited by 99
Zhang, Z., & Feng, S. (2006) · Biomacromolecules · doi:10.1021/bm050953v · Cited by 98
Evaluation of cationized rat albumin as a potential blood-brain barrier drug transport vector.
Pardridge, W. M., Triguero, D., Buciak, J. L., & Yang, J. (1990) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)23180-9 · Cited by 97
Plasma Protein Adsorption of Tween 80- and Poloxamer 188-stabilized Solid Lipid Nanoparticles
Göppert, T. M., & Müller, R. H. (2003) · Journal of drug targeting · doi:10.1080/10611860310001615956 · Cited by 95
Blood-Brain Barrier Transport of Reduced Folic Acid
Wu, D., & Pardridge, W. M. (1999) · Pharmaceutical Research · doi:10.1023/a:1018829920158 · Cited by 94
Halmos, T., Santarromana, M., Antonakis, K., & Scherman, D. (1996) · European Journal of Pharmacology · doi:10.1016/s0014-2999(96)00796-0 · Cited by 93
Site-directed immobilization of proteins
Domen, P. L., Nevens, J. R., Mallia, A. K., Hermanson, G. T., & Klenk, D. (1990) · Journal of Chromatography A · doi:10.1016/s0021-9673(01)93763-x · Cited by 92
Weinstein, J. N., Blumenthal, R. P., Sharrow, S. O., & Henkart, P. A. (1978) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(78)90047-0 · Cited by 90
Li, Y., Ogris, M., Wagner, E., Pelisek, J., & Rüffer, M. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(03)00211-4 · Cited by 89
The Blood-Brain Barrier and Brain Drug Delivery
Koziara, J. M., Lockman, P. R., Allen, D. D., & Mumper, R. J. (2006) · Journal of Nanoscience and Nanotechnology · doi:10.1166/jnn.2006.441 · Cited by 86
Non-invasive drug delivery to the human brain using endogenous blood–brain barrier transport systems
Pardridge, W. M. (1999) · Pharmaceutical Science & Technology Today · doi:10.1016/s1461-5347(98)00117-5 · Cited by 85
Peracchia, M. T., Vauthier, C., Puisieux, F., & Couvreur, P. (1997) · Journal of Biomedical Materials Research · Cited by 84
Salem, A. K., Cannizzaro, S. M., Davies, M. C., Tendler, S. J. B., Roberts, C. J., Williams, P. M., & Shakesheff, K. M. (2001) · Biomacromolecules · doi:10.1021/bm010030+ · Cited by 84
Krauel, K., Davies, N. M., Hook, S. M., & Rades, T. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.04.013 · Cited by 83
Chimeric peptides as a vehicle for peptide pharmaceutical delivery through the blood-brain barrier
Pardridge, W. M., Kumagai, A. K., & Eisenberg, J. (1987) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(87)90726-1 · Cited by 82
Endogenous carriers and ligands in non-immunogenic site-specific drug delivery
Vyas, S. P., & Sihorkar, V. (2000) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00067-3 · Cited by 82
Cornford, E. M., Young, D., Paxton, J. W., Finlay, G. J., Wilson, W. R., & Pardridge, W. M. (1992) · PubMed · Cited by 79
Béduneau, A., Saulnier, P., Anton, N., Hindré, F., Passirani, C., Rajérison, H., Noiret, N., & Benoît, J. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-9061-y · Cited by 79
Self-citationStructures of Nanoparticles Prepared from Oil-in-Water Emulsions
Sjöström, B., Kaplun, A., Talmon, Y., & Cabane, B. (1995) · Pharmaceutical Research · doi:10.1023/a:1016278302046 · Cited by 77
Hamaguchi, T., Matsumura, Y., Nakanishi, Y., Muro, K., Yamada, Y., Shimada, Y., Shirao, K., Niki, H., Hosokawa, S., Tagawa, T., et al. (2004) · Cancer Science · doi:10.1111/j.1349-7006.2004.tb02495.x · Cited by 74
Receptor-Specific Delivery of Liposomes Via Folate-Peg-Chol
Guo, W., Lee, T., Sudimack, J. J., & Lee, R. J. (2000) · Journal of Liposome Research · doi:10.3109/08982100009029385 · Cited by 74
BBB-Genomics: creating new openings for brain-drug targeting
Pardridge, W. M. (2001) · Drug Discovery Today · doi:10.1016/s1359-6446(01)01721-4 · Cited by 70
Azmin, M. N., Stuart, J. F. B., & Florence, A. T. (1985) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00258124 · Cited by 69
Müller, R. H., Lherm, C., Herbort, J., Blunk, T., & Couvreur, P. (1992) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(92)90209-k · Cited by 69
Absence of Toxicity of Chronic Weekly Intravenous Gene Therapy with Pegylated Immunoliposomes
Zhang, Y., Boado, R. J., & Pardridge, W. M. (2003) · Pharmaceutical Research · doi:10.1023/b:pham.0000003375.13655.f9 · Cited by 69
Amine-Reactive Biodegradable Diblock Copolymers
Teßmar, J., Mikos, A. G., & Göpferich, A. M. (2001) · Biomacromolecules · doi:10.1021/bm015608u · Cited by 69
Structure and function of the transferrin receptor.
Seligman, P. A. (1983) · PubMed · Cited by 67
Pardridge, W. M., Triguero, D., & Buciak, J. L. (1990) · Endocrinology · doi:10.1210/endo-126-2-977 · Cited by 65
Local delivery of mitoxantrone for the treatment of malignant brain tumors in rats
DiMeco, F., Li, K. W., Tyler, B., Wolf, A. S., Brem, H., & Olivi, A. (2002) · Journal of neurosurgery · doi:10.3171/jns.2002.97.5.1173 · Cited by 63
Mora, M., Sagristá, M. L., Trombetta, D., Bonina, F. P., Pasquale, A. D., & Saija, A. (2002) · Pharmaceutical Research · doi:10.1023/a:1020440229102 · Cited by 61
Imaging brain tumors by targeting peptide radiopharmaceuticals through the blood-brain barrier.
Kurihara, A., & Pardridge, W. M. (1999) · PubMed · Cited by 61
Immunohistochemical localization of apolipoprotein E in human glial neoplasms.
Murakami, M., Ushio, Y., Morino, Y., Ohta, T., & Matsukado, Y. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113568 · Cited by 60
Pharmacological blood-brain barrier modification for selective drug delivery
Cloughesy, T. F., & Black, K. L. (1995) · Journal of Neuro-Oncology · doi:10.1007/bf01060218 · Cited by 60
Vector-mediated peptide drug delivery to the brain
Pardridge, W. M. (1995) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00007-t · Cited by 55
Cited by
Nanomaterials for Theranostics: Recent Advances and Future Challenges
Lim, E.-K., Kim, T., Paik, S., Haam, S., Huh, Y.-M., & Lee, K. (2015) · Chemical Reviews · doi:10.1021/cr300213b · Cited by 1,233
Effect of Zeta Potential on the Properties of Nano-Drug Delivery Systems - A Review (Part 1)
Honary, S., & Zahir, F. (2013) · Tropical Journal of Pharmaceutical Research · doi:10.4314/tjpr.v12i2.19 · Cited by 1,138
Nanomedicine(s) under the Microscope
Duncan, R., & Gaspar, R. (2011) · Molecular Pharmaceutics · doi:10.1021/mp200394t · Cited by 981
Methods for the Preparation and Manufacture of Polymeric Nanoparticles
Vauthier, C., & Bouchemal, K. (2009) · Pharmaceutical Research · doi:10.1007/s11095-008-9800-3 · Cited by 929
Ge, Z., & Liu, S. (2013) · Chemical Society Reviews · doi:10.1039/c3cs60048c · Cited by 914
Metadata
- Authors
- Béduneau, A., Saulnier, P., & Benoit, J.-P.
- Venue
- Biomaterials
- Publisher
- Elsevier BV
- Published
- 2007-11
- Volume
- 28
- Issue
- 33
- Pages
- 4947-4967
- ISSN
- 0142-9612 (ISSN-L)
- OpenAlex
- W2014537537
- Cited by
- 424
- References
- 218
- FWCI
- 10.76
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.